Applied DNA Sciences, Inc. (APDN)

Market Cap	5.73M
Revenue (ttm)	9.00M
Net Income (ttm)	-7.29M
Shares Out	16.98M
EPS (ttm)	-0.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130,053
Open	0.338
Previous Close	0.333
Day's Range	0.330 - 0.376
52-Week Range	0.310 - 1.860
Beta	0.09
Analysts	Strong Buy
Price Target	1.50 (+347.76%)
Earnings Date	May 9, 2024

About APDN

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-base...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1983
• Employees: 52
• Stock Exchange: NASDAQ
• Ticker Symbol: APDN

Financial Performance

In 2023, APDN's revenue was $13.37 million, a decrease of -26.43% compared to the previous year's $18.17 million. Losses were -$9.95 million, 18.7% more than in 2022.

Analyst Forecast

According to one analyst, the rating for APDN stock is "Strong Buy" and the 12-month stock price forecast is $1.5.

Price Target

$1.5

(347.76% upside)

Analyst Consensus: Strong Buy